In the meantime, the proportion of CD206+ macrophages in the mice's tumor tissues that received combination treatment was decreased by 12.85% (Figure S12E, Supporting Information), thus diminishing immunosuppressive effects on promoting tumor development and progression. Here, MRC1 is linked to neoplasm.